The subdelegate of the Government knows the projects in which the researchers of the CSIC in Valladolid are currently working

• Canales held a working meeting today with officials in Valladolid of the Higher Council of Scientific Research (CSIC), the State Agency for Scientific Research and Technological Development, attached to the Ministry of Science, Innovation and Universities. • The Institute of Biomedicine and Molecular Genetics (IBGM) of Valladolid currently manages eleven research projects on the cellular and molecular basis of the most important groups of diseases. • The transfer of the result of these research in the technological field offers companies the possibility of commercially developing the advances.

April 24, 2024. The deputy delegate of the Government in Valladolid, Jacinto Canales, held today a meeting with the leaders in Valladolid of the Higher Council of Scientific Research (CSIC), the State Agency for Scientific Research and Technological Development, attached to the Ministry of Science, Innovation and Universities.

Jacinto Canales has been able to know in this meeting with the manager of the IBGM, Alain Blanquer, and the head of the CSIC in Valladolid, Juan Pablo Duque, the management of the technological transfer of the result of the investigations to the companies that can commercially develop these findings. In particular, the development of the last two patents, fruit of that work, one of them, of products active in diseases of the immune system and the other for the diagnosis of hereditary diseases, has been commented.

Jacinto Canales stressed “the importance of transferring the fruits of publicly funded research to the business fabric so that society can benefit from the advances of such research.”

New therapies

At the meeting, the subdelegate was informed about the eleven research projects currently managed by the Institute of Biomedicine and Molecular Genetics (IBGM) of Valladolid, which studies the cellular and molecular bases of the most important groups of diseases: cardiovascular, respiratory, inflammatory and metabolic, the immune system, cancer, aging and the neurological and neurodegenerative pathologies associated with it.

The goal of ongoing research is to find advanced molecular diagnostic methods and new therapies, particularly cell therapy and immunotherapy.

Among other functions, the Institute is the source and main contributor to the genetic diagnosis of susceptibility to family breast and colon cancer in Castilla y León.

The IBGM has three large research units, consisting of 26 groups and more than 160 people, including technicians, researchers, administration and services.